Form 4: Addus CFO Brian Poff Reports Routine Stock Transactions

Addus HomeCare Corp's EVP and CFO, Brian Poff, reported the acquisition of 11,431 shares of common stock through a restricted stock award and the subsequent sale of 1,858 shares to cover tax obligations under a pre-established 10b5-1 plan.

Summary

• Brian Poff, Executive Vice President and Chief Financial Officer of Addus HomeCare Corp (ADUS), acquired 11,431 shares of common stock on February 20, 2026, at a price of $0 per share.
• These acquired shares are restricted stock awards that will vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and acceleration upon a change in control.
• Poff subsequently disposed of 1,858 shares of common stock on February 23, 2026, at a price of $114.91 per share.
• This sale was executed pursuant to a Rule 10b5-1(c) plan, adopted on March 4, 2025, specifically to satisfy tax obligations arising from the vesting of restricted stock awards.
• Following these transactions, Brian Poff's direct beneficial ownership of Addus HomeCare Corp common stock stands at 66,553 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive, routine filing. The restricted stock award is a positive for executive retention and alignment, while the sale for tax purposes is a neutral, expected event that does not reflect negatively on the company's prospects.

Positives

• The acquisition of 11,431 shares through a restricted stock award demonstrates continued equity-based compensation for a key executive, aligning management's interests with shareholders.
• The vesting schedule over three years (2027-2029) indicates a long-term retention strategy for the EVP and CFO.

Negatives

• The sale of 1,858 shares, while for tax purposes, represents a reduction in the executive's direct holdings, though it is a common practice for restricted stock vesting.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that equity compensation, such as restricted stock awards, is a standard practice across the healthcare services industry, including home care providers like Addus HomeCare. These awards are designed to incentivize long-term performance and retain key executives. The subsequent sale of shares to cover tax liabilities upon vesting is also a routine and expected event for executives receiving such compensation.

Stakeholder Impact

• Shareholders: The transactions are routine and do not indicate a significant change in the company's operational or financial outlook. The executive's continued equity ownership aligns interests.
• Employees: No direct impact mentioned, but executive compensation practices can influence overall company culture and morale.

Next Steps

• Portions of the acquired restricted stock will vest on February 20, 2027, February 20, 2028, and February 20, 2029.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation and tax obligations. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transactions are expected and do not alter the fundamental investment thesis for Addus HomeCare Corp.

Keywords

Addus HomeCare, ADUS, Brian Poff, CFO, Insider Trading, Form 4, Restricted Stock, Stock Award, 10b5-1 Plan, Executive Compensation, Beneficial Ownership